Bulletin 357 launched - Branded mesalazine

Mesalazine preparations are compared to support medicine formulary choice and potential switches from Asacol® to Octasa® in suitable individuals.

Implementation resources include an oral mesalazine comparison table, audit, text message and patient letter templates, visual data pack, infobriefs, searches and educational slideset.

View >